not for another few weeks if you please although i suspect the quarterly will define the tone in the short term.
I suspect management will be keeping a relatively low profile as the various business streams are matured.
This will ensure maximum immediate value will be extracted. Nothing worse than a cheap takeover leaving the punters out of pocket.
As a minimum we want.
1. Cash flow positive covering all R&D costs
2. Global distribution of Evolis + and associated health care products
3. Successful Ph1 Therapeutics trial with tri-body anti-body
4. Multiple cancer diagnostic tests with Quest
5. further product development with Pacific Edge and Global dist of CX Bladder
5. Licensing deal with Fujikura Kasei with royalties
Without this suite of revenue producing streams we are being undersold. 1$B plus imo.
GLTA
- Forums
- ASX - By Stock
- AN1
- What's up Doc...
AN1
anagenics limited
Add to My Watchlist
0.00%
!
0.6¢

What's up Doc..., page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.977M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 850000 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 4250000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 850000 | 0.005 |
8 | 8723692 | 0.004 |
6 | 6609137 | 0.003 |
2 | 2800000 | 0.002 |
3 | 2600000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 4250000 | 2 |
0.008 | 653713 | 2 |
0.009 | 520000 | 1 |
0.010 | 500000 | 1 |
0.015 | 200000 | 1 |
Last trade - 16.30pm 08/07/2025 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
Day chart unavailable